首页> 外国专利> NUCLEIC ACID NANOPARTICLES, PHARMACEUTICAL COMPOSITION COMPRISING SAME, DRUG COMPRISING DOXORUBICIN AND PREPARATION METHOD THEREFOR

NUCLEIC ACID NANOPARTICLES, PHARMACEUTICAL COMPOSITION COMPRISING SAME, DRUG COMPRISING DOXORUBICIN AND PREPARATION METHOD THEREFOR

机译:核酸纳米颗粒,包含其的药物组合物,包含多柔比星的药物和制备方法

摘要

Disclosed are nucleic acid nanoparticles, a pharmaceutical composition comprising the same, a drug comprising doxorubicin and a preparation method thereof. The nucleic acid nanoparticles have a nucleic acid structural domain, the nucleic acid structural domain includes a sequence a, a sequence b and a sequence c; the sequence a includes a sequence a1 or a sequence obtained by insertion, deletion or substitution of at least one base in the sequence a1, the sequence b includes a sequence b1 or a sequence obtained by insertion, deletion or substitution of at least one base in the sequence b1, and the sequence c includes a sequence d or a sequence obtained by insertion, deletion or substitution of at least one base in the sequence d. The nucleic acid nanoparticles are capable of, by means of including the three sequences described above or variant sequences thereof, not only self-assembling to form the nucleic acid structural domain, but also serving as a carrier. While served as the carrier, the nucleic acid nanoparticles are not only capable of loading and delivering nucleic acid drugs, but are also suitable for loading and delivering other biologically active substances such as chemical drugs.
机译:公开了核酸纳米颗粒,一种药物组合物,其包含该药物组合物,其包含多柔比星的药物及其制备方法。核酸纳米颗粒具有核酸结构结构域,核酸结构结构域包括序列A,序列B和序列C;序列A包括通过在序列A1中插入,缺失或取代至少一个碱基获得的序列A1或序列,序列B包括通过插入,删除或替换至少一个基础而获得的序列B1或序列序列B1和序列C包括通过在序列D中插入,删除或替换至少一个碱基获得的序列D或序列。核酸纳米颗粒能够通过包括上述三个序列或其变体序列,不仅自组装以形成核酸结构结构域,而且还可作为载体。虽然作为载体作为载体,核酸纳米颗粒不仅能够加载和递送核酸药物,而且还适用于装载和递送其他生物活性物质,例如化学药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号